Page last updated: 2024-08-23

vindesine and Pyrexia

vindesine has been researched along with Pyrexia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bedikian, AY; Bodey, GP; Gutterman, JU; Hersh, EM; Maroun, J; Valdivieso, M1
Fujii, M; Fukuoka, M; Furuse, K; Ikegami, H; Katakami, N; Nakai, Y; Nakajima, S; Negoro, S; Takada, Y; Yamori, S1
Mempel, K; Pfetsch, M; Reiter, A; Riehm, H; Schrappe, M; Schwab, G; Welte, K1
Bastion, Y; Bosly, A; Coiffier, B; Dabouz-Harrouche, F; Deconinck, E; Dupriez, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Marit, G; Marolleau, JP; Reyes, F; Tilly, H; Yver, A1

Trials

3 trial(s) available for vindesine and Pyrexia

ArticleYear
[A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Drug Administration Schedule; Female; Fever; Humans; Injections, Intravenous; Leukopenia; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine; Vinorelbine

1995
A randomized phase-III study of the efficacy of granulocyte colony-stimulating factor in children with high-risk acute lymphoblastic leukemia. Berlin-Frankfurt-Münster Study Group.
    Blood, 1996, Apr-15, Volume: 87, Issue:8

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Etoposide; Female; Fever; Filgrastim; Gastrointestinal Diseases; Germany; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Ifosfamide; Infant; Infection Control; Life Tables; Male; Mercaptopurine; Methotrexate; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prospective Studies; Recombinant Proteins; Risk; Survival Analysis; Thioguanine; Vincristine; Vindesine

1996
Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fever; Granulocyte Colony-Stimulating Factor; Humans; Infections; Lenograstim; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neutropenia; Placebos; Recombinant Proteins; Survival Rate; Treatment Outcome; Vindesine

1997

Other Studies

1 other study(ies) available for vindesine and Pyrexia

ArticleYear
Evaluation of vindesine and MER in colorectal cancer.
    Cancer, 1980, Aug-01, Volume: 46, Issue:3

    Topics: Adult; Aged; Agranulocytosis; BCG Vaccine; Colonic Neoplasms; Drug Evaluation; Female; Fever; Humans; Immunotherapy; Injections, Intravenous; Male; Middle Aged; Peripheral Nervous System Diseases; Prognosis; Rectal Neoplasms; Thrombocytopenia; Vinblastine; Vindesine

1980